ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Gori To Leave NCI For Job At Franklin Institute

April 18, 1980

ACD Honors Sullivan, Who Reaffirms Anti-Smoking Effort

June 29, 1990

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

Pittsburgh Broadens Misconduct Inquiry

June 3, 1994

In Brief: Curt Appointment Now Official; Bipartisan Effort Seeks $150 Million FDA Budget Increase

April 21, 1989

In Brief: AACR Publishes Position Paper On Smoking, Lung Cancer; Beahrs Interim ACS Cancer Dept. Head NCI Advisory Group, Other Cancer Meetings

January 4, 1985